Amalgamated Bank Sells 2,423 Shares of Maximus, Inc. (NYSE:MMS)

Amalgamated Bank cut its stake in shares of Maximus, Inc. (NYSE:MMS) by 7.6% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 29,537 shares of the health services provider’s stock after selling 2,423 shares during the quarter. Amalgamated Bank’s holdings in Maximus were worth $2,531,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Rise Advisors LLC raised its position in Maximus by 1,445.0% in the 1st quarter. Rise Advisors LLC now owns 309 shares of the health services provider’s stock worth $26,000 after buying an additional 289 shares during the last quarter. GAMMA Investing LLC grew its stake in shares of Maximus by 224.5% in the second quarter. GAMMA Investing LLC now owns 344 shares of the health services provider’s stock worth $29,000 after acquiring an additional 238 shares during the period. Blue Trust Inc. raised its holdings in shares of Maximus by 201.5% during the second quarter. Blue Trust Inc. now owns 392 shares of the health services provider’s stock valued at $33,000 after purchasing an additional 262 shares during the last quarter. Kapitalo Investimentos Ltda bought a new position in Maximus during the fourth quarter valued at approximately $52,000. Finally, Archer Investment Corp boosted its holdings in Maximus by 8,788.9% in the second quarter. Archer Investment Corp now owns 800 shares of the health services provider’s stock worth $69,000 after purchasing an additional 791 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors.

Maximus Price Performance

Shares of MMS opened at $91.77 on Wednesday. The firm has a market cap of $5.58 billion, a PE ratio of 24.09 and a beta of 0.76. Maximus, Inc. has a 1-year low of $72.39 and a 1-year high of $93.97. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.61. The firm has a fifty day simple moving average of $89.82 and a two-hundred day simple moving average of $86.23.

Maximus (NYSE:MMS) last posted its earnings results on Wednesday, August 7th. The health services provider reported $1.74 earnings per share for the quarter, beating analysts’ consensus estimates of $1.47 by $0.27. The company had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a return on equity of 20.91% and a net margin of 5.59%. Maximus’s revenue was up 10.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.78 earnings per share. On average, equities analysts anticipate that Maximus, Inc. will post 6.12 EPS for the current year.

Maximus Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Saturday, August 31st. Investors of record on Thursday, August 15th were issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.31%. The ex-dividend date of this dividend was Thursday, August 15th. Maximus’s payout ratio is 31.50%.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.